{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T16:14:34Z","timestamp":1687623274626},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T00:00:00Z","timestamp":1390348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T00:00:00Z","timestamp":1390348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s12029-013-9566-7","type":"journal-article","created":{"date-parts":[[2014,1,21]],"date-time":"2014-01-21T06:59:23Z","timestamp":1390287563000},"page":"168-180","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["90Y Glass Microspheres for the Treatment of Unresectable Metastatic Liver Disease from Chemotherapy-Refractory Gastrointestinal Cancers: A Pilot Study"],"prefix":"10.1007","volume":"45","author":[{"given":"Nicholas","family":"Fidelman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Robert K.","family":"Kerlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall A.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew G.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen P.","family":"Kohi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Pallav","family":"Kolli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily K.","family":"Bergsland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Kate","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew H.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Michael","family":"Korn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan M.","family":"McWhirter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Luan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan P.","family":"Venook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,22]]},"reference":[{"key":"9566_CR1","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s11605-006-0061-3","volume":"11","author":"TM Pawlik","year":"2007","unstructured":"Pawlik TM, Choti MA. Surgical therapy for colorectal metastases to the liver. J Gastrointest Surg. 2007;11:1057\u201377.","journal-title":"J Gastrointest Surg"},{"key":"9566_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006039.pub4","volume":"16","author":"A Al-Asfoor","year":"2008","unstructured":"Al-Asfoor A, Feorowicz Z, Lodge M. Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases. Cochrane Database Syst Rev. 2008;16, CD006039. doi:10.1002\/14651858.CD006039.pub4.","journal-title":"Cochrane Database Syst Rev"},{"key":"9566_CR3","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s11938-004-0002-8","volume":"7","author":"JM Llovet","year":"2004","unstructured":"Llovet JM. Treatment of hepatocellular cancer. Curr Treat Options Gastroenterol. 2004;7:431\u201341.","journal-title":"Curr Treat Options Gastroenterol"},{"key":"9566_CR4","first-page":"871","volume":"24","author":"HA Zeissman","year":"1983","unstructured":"Zeissman HA, Thrall JH, Gyves JW, Ensminger WD, Niederhuber JE, Tuscan M, et al. Quantitative hepatic arterial perfusion scintigraphy and starch microspheres in cancer chemotherapy. J Nucl Med. 1983;24:871\u20135.","journal-title":"J Nucl Med"},{"key":"9566_CR5","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/cncr.23685","volume":"113","author":"J King","year":"2008","unstructured":"King J, Quinn R, Glenn DM, Janssen J, Tong D, Liaw W, et al. Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases. Cancer. 2008;113:921\u20139. doi:10.1002\/cncr.23685.","journal-title":"Cancer"},{"key":"9566_CR6","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.jvir.2008.05.013","volume":"19","author":"TF Jakobs","year":"2008","unstructured":"Jakobs TF, Hoffmann RT, Dehm K, Trumm C, Stemmler HJ, Tatsch K, et al. Hepatic Yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases. J Vasc Interv Radiol. 2008;19:1187\u201395. doi:10.1016\/j.jvir.2008.05.013.","journal-title":"J Vasc Interv Radiol"},{"key":"9566_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.jvir.2008.01.009","volume":"19","author":"TF Jakobs","year":"2008","unstructured":"Jakobs TF, Hoffmann RT, Fischer T, Stemmler HJ, Tatsch K, La Fougere C, et al. Radioembolization in patients with hepatic metastases from breast cancer. J Vasc Interv Radiol. 2008;19:683\u201390. doi:10.1016\/j.jvir.2008.01.009.","journal-title":"J Vasc Interv Radiol"},{"key":"9566_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1148\/radiol.2472062029","volume":"247","author":"KT Sato","year":"2008","unstructured":"Sato KT, Lewandowski RJ, Mulcahy MF, Atassi B, Ryu RK, Gates VL, et al. Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres\u2014safety, efficacy, and survival. Radiology. 2008;247:507\u201315. doi:10.1148\/radiol.2472062029.","journal-title":"Radiology"},{"key":"9566_CR9","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1097\/SLA.0b013e3181728a45","volume":"247","author":"TK Rhee","year":"2008","unstructured":"Rhee TK, Lewandowski RJ, Liu DM, Mulcahy MF, Takahashi G, Hansen PD, et al. 90Y radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience. Ann Surg. 2008;247:1029\u201335. doi:10.1097\/SLA.0b013e3181728a45.","journal-title":"Ann Surg"},{"key":"9566_CR10","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.ijrobp.2005.12.051","volume":"65","author":"AS Kennedy","year":"2006","unstructured":"Kennedy AS, Coldwell D, Nutting C, Murthy R, Wertman Jr DE, Loehr SP, et al. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys. 2006;65:412\u201325.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9566_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/571261","author":"GW Nace","year":"2011","unstructured":"Nace GW, Steel JL, Amesur N, Zajko A, Nastasi BE, Joyce J, et al. Yttrium-90 radioembolization for colorectal cancer liver metastases: a single institution experience. Int J Surg Oncol. 2011. doi:10.1155\/2011\/571261.","journal-title":"Int J Surg Oncol"},{"key":"9566_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/COC.0b013e31815e4557","volume":"31","author":"AS Kennedy","year":"2008","unstructured":"Kennedy AS, Dezarn WA, McNeillie P, Coldwell D, Nutting C, Carter D, et al. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Ymicrospheres: early results in 148 patients. Am J Clin Oncol. 2008;31:271\u20139. doi:10.1097\/COC.0b013e31815e4557.","journal-title":"Am J Clin Oncol"},{"key":"9566_CR13","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jvir.2007.02.019","volume":"18","author":"AK Bangash","year":"2007","unstructured":"Bangash AK, Atassi B, Kaklamani V, Rhee TK, Yu M, Lewandowski RJ, et al. 90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival. J Vasc Interv Radiol. 2007;18:621\u20138.","journal-title":"J Vasc Interv Radiol"},{"key":"9566_CR14","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1080\/07357900802620893","volume":"27","author":"AS Kennedy","year":"2009","unstructured":"Kennedy AS, Nutting C, Jakobs T, Cianni R, Notarianni E, Ofer A, et al. A first report of radioembolization for hepatic metastases from ocular melanoma. Cancer Investig. 2009;27:682\u201390. doi:10.1080\/07357900802620893.","journal-title":"Cancer Investig"},{"key":"9566_CR15","doi-asserted-by":"publisher","first-page":"468","DOI":"10.2214\/AJR.10.4881","volume":"196","author":"CF Gonsalves","year":"2011","unstructured":"Gonsalves CF, Eschelman DJ, Sullivan KL, Anne PR, Doyle L, Sato T. Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: a single-institution experience. AJR. 2011;196:468\u201373. doi:10.2214\/AJR.10.4881.","journal-title":"AJR"},{"key":"9566_CR16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s00270-012-0373-5","volume":"36","author":"A Klingenstein","year":"2013","unstructured":"Klingenstein A, Haug AR, Zech CJ, Schaller UC. Radioembolization as locoregional therapy of hepatic metastases in uveal melanoma patients. Cardiovasc Intervent Radiol. 2013;36:158\u201365. doi:10.1007\/s00270-012-0373-5.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"9566_CR17","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1002\/cncr.23818","volume":"113","author":"SM Ibrahim","year":"2008","unstructured":"Ibrahim SM, Mulcahy MF, Lewandowski RJ, Sato KT, Ryu RK, Masterson EJ, et al. Treatment of unresectable cholangiocarcinoma using Yttrium-90 microspheres: results from a pilot study. Cancer. 2008;113:2119\u201328. doi:10.1002\/cncr.23818.","journal-title":"Cancer"},{"key":"9566_CR18","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1245\/s10434-009-0777-x","volume":"17","author":"A Saxena","year":"2010","unstructured":"Saxena A, Bester L, Chua TC, Chu FC. Morris DL (2010) Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment option. Ann Surg Oncol. 2010;17:484\u201391. doi:10.1245\/s10434-009-0777-x.","journal-title":"Ann Surg Oncol"},{"key":"9566_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00270-011-0142-x","volume":"35","author":"RT Hoffmann","year":"2012","unstructured":"Hoffmann RT, Paprottka PM, Schon A, Bamberg F, Haug A, Durr EM, et al. Trnasarterial hepatic Yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival. Cardiovasc Intervent Radiol. 2012;35:105\u201316. doi:10.1007\/s00270-011-0142-x.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"9566_CR20","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.jvir.2013.02.031","volume":"24","author":"S Mouli","year":"2013","unstructured":"Mouli S, Memon K, Baker T, Benson 3rd AB, Mulcahy MF, Gupta R, et al. Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis. J Vasc Interv Radiol. 2013;24:1227\u201334. doi:10.1016\/j.jvir.2013.02.031.","journal-title":"J Vasc Interv Radiol"},{"key":"9566_CR21","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s00270-012-0463-4","volume":"36","author":"S Rafi","year":"2013","unstructured":"Rafi S, Piduru SM, El-Rayes B, Kauh JS, Kooby DA, Sarmiento JM, et al. Yttrium-90 radioembolization for unresectable standard-chemorefractory intrahepatic cholangiocarcinoma: survival, efficacy, and safety study. Cardiovasc Intervent Radiol. 2013;36:440\u20138. doi:10.1007\/s00270-012-0463-4.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"9566_CR22","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/sj.bjc.6605770","volume":"103","author":"M Cosimelli","year":"2010","unstructured":"Cosimelli M, Golfieri R, Cagol PP, Carpanese L, Sciuto R, Maini CL, et al. Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy-refractory colorectal liver metastases. Br J Cancer. 2010;103:324\u201331. doi:10.1038\/sj.bjc.6605770.","journal-title":"Br J Cancer"},{"key":"9566_CR23","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1200\/JCO.2010.28.5643","volume":"28","author":"A Hendlisz","year":"2010","unstructured":"Hendlisz A, Van den Eynde M, Peeters M, Maleux G, Lambert B, Vannoote J, et al. Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy. J Clin Oncol. 2010;28:3687\u201394. doi:10.1200\/JCO.2010.28.5643.","journal-title":"J Clin Oncol"},{"key":"9566_CR24","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00270-007-9064-z","volume":"30","author":"RJ Lewandowski","year":"2007","unstructured":"Lewandowski RJ, Sato KT, Atassi B, Ryu RK, Nemcek Jr AA, Kulik L, et al. Radioembolization with 90Y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol. 2007;30:571\u201392.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"9566_CR25","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.jvir.2011.06.007","volume":"22","author":"MHK Abdelmaksoud","year":"2011","unstructured":"Abdelmaksoud MHK, Louie JD, Kothary N, Hwang GL, Kuo WT, Hofmann LV, et al. Consolidation of hepatic arterial inflow by embolization of variant hepatic arteries in preparation for Yttrium-90 radioembolization. J Vasc Interv Radiol. 2011;22:1364\u201371. doi:10.1016\/j.jvir.2011.06.014.","journal-title":"J Vasc Interv Radiol"},{"key":"9566_CR26","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1097\/01.RVI.0000233785.75257.9A","volume":"17","author":"R Salem","year":"2006","unstructured":"Salem R, Thurston KG. Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. J Vasc Interv Radiol. 2006;17:1251\u201378.","journal-title":"J Vasc Interv Radiol"},{"issue":"suppl 2","key":"9566_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1634\/theoncologist.13-S2-19","volume":"13","author":"R Pazdur","year":"2008","unstructured":"Pazdur R. Endpoints for assessing drug activity in clinical trials. Oncologist. 2008;13 suppl 2:19\u201321. doi:10.1634\/theoncologist.13-S2-19.","journal-title":"Oncologist"},{"key":"9566_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1479-5876-2-37","volume":"2","author":"RE Carter","year":"2004","unstructured":"Carter RE, Woolson RF. Statistical design considerations for pilot studies transitioning therapies from the bench to the bedside. J Transl Med. 2004;2:37\u201341.","journal-title":"J Transl Med"},{"key":"9566_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1198\/000313002753631295","volume":"56","author":"RL Winkler","year":"2002","unstructured":"Winkler RL, Smith JE, Fryback DG. The role of informative priors in zero-numerator problems: being conservative versus being candid. Am Stat. 2002;56:1\u20134.","journal-title":"Am Stat"},{"key":"9566_CR30","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.ijrobp.2011.07.041","volume":"83","author":"K Memon","year":"2012","unstructured":"Memon K, Lewandowski RJ, Mulcahy MF, Riaz A, Ryu RK, Sato KT, et al. Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes. Int J Radiat Oncol Biol Phys. 2012;83:887\u201394. doi:10.1016\/j.ijrobp.2011.07.041.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9566_CR31","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/hep.23944","volume":"52","author":"P Hilgard","year":"2010","unstructured":"Hilgard P, Hamami M, Fouly AE, Scherag A, Muller S, Ertle J, et al. Radioembolization with Yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival. Hepatology. 2010;52:1741\u20139. doi:10.1002\/hep.23944.","journal-title":"Hepatology"},{"key":"9566_CR32","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1634\/theoncologist.2011-0372","volume":"17","author":"MA Lewis","year":"2012","unstructured":"Lewis MA, Jaramillo S, Roberts L, Fleming CJ, Rubin J, Grothey A. Hepatic artery embolization for neuroendocrine tumors: postprocedural management and complications. Oncologist. 2012;17:725\u201331. doi:10.1634\/theoncologist.2011-0372.","journal-title":"Oncologist"},{"key":"9566_CR33","first-page":"1074","volume":"16","author":"C Ahuja","year":"2010","unstructured":"Ahuja C, Chadha M, Critchfield JJ. Intraoperative carcinoid hypertensive crisis precipitated by Yttrium-90 microsphere radioembolotherapy. Endocr Pract. 2010;16:1074\u20135.","journal-title":"Endocr Pract"},{"key":"9566_CR34","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/bja\/aen237","volume":"101","author":"JG Castillo","year":"2008","unstructured":"Castillo JG, Filsoufi F, Adams DH, Raikhelkar J, Zaku B, Fischer GW. Management of patients undergoing multivalvular surgery for carcinoid heart disease: the role of the anaesthetist. Br J Anaesth. 2008;101:618\u201326. doi:10.1093\/bja\/aen237.","journal-title":"Br J Anaesth"},{"key":"9566_CR35","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/bjs.6931","volume":"97","author":"CQ Cao","year":"2010","unstructured":"Cao CQ, Yan TD, Bester L, Liauw W, Morris DL. Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases. Br J Surg. 2010;97:537\u201343. doi:10.1002\/bjs.6931.","journal-title":"Br J Surg"},{"key":"9566_CR36","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s00270-011-0248-1","volume":"35","author":"PM Paprottka","year":"2012","unstructured":"Paprottka PM, Hoffmann RT, Haug A, Sommer WH, Raessler F, Trumm CG, et al. Radioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using Yttrium-90 microspheres. Cardiovasc Intervent Radiol. 2012;35:334\u201342. doi:10.1007\/s00270-011-0248-1.","journal-title":"Cardiovasc Intervent Radiol"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-013-9566-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-013-9566-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-013-9566-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-013-9566-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T10:41:08Z","timestamp":1628592068000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-013-9566-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,22]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["9566"],"URL":"https:\/\/doi.org\/10.1007\/s12029-013-9566-7","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,22]]},"assertion":[{"value":"22 January 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}